| Primary |
| Back Pain |
60.0% |
| Pyrexia |
40.0% |
|
| Hepatic Enzyme Increased |
50.0% |
| Tumour Necrosis |
50.0% |
|
| Secondary |
| Pain |
21.6% |
| Product Used For Unknown Indication |
15.4% |
| Hypertension |
9.5% |
| Bronchitis |
8.4% |
| Suicide Attempt |
7.6% |
| Drug Use For Unknown Indication |
4.2% |
| Supplementation Therapy |
3.9% |
| Intentional Overdose |
3.4% |
| Pyrexia |
3.1% |
| Intervertebral Disc Degeneration |
2.8% |
| Prophylaxis |
2.8% |
| Cardiac Failure |
2.5% |
| Metastatic Malignant Melanoma |
2.2% |
| Psoas Abscess |
2.2% |
| Atrial Fibrillation |
2.0% |
| Back Pain |
1.7% |
| Bone Pain |
1.7% |
| Nausea |
1.7% |
| Renal Colic |
1.7% |
| Thrombosis Prophylaxis |
1.7% |
|
| Dementia |
13.6% |
| Agranulocytosis |
7.6% |
| Suicide Attempt |
7.6% |
| Leukopenia |
6.1% |
| Stevens-johnson Syndrome |
6.1% |
| Toxic Epidermal Necrolysis |
6.1% |
| Trisomy 21 |
6.1% |
| Lipid Metabolism Disorder |
4.5% |
| Maternal Exposure During Pregnancy |
4.5% |
| Petechiae |
4.5% |
| Thrombocytopenia |
4.5% |
| Vomiting |
4.5% |
| Abortion Spontaneous |
3.0% |
| Acute Generalised Exanthematous Pustulosis |
3.0% |
| Acute Hepatic Failure |
3.0% |
| Autoimmune Thrombocytopenia |
3.0% |
| Bladder Tamponade |
3.0% |
| Erythema Multiforme |
3.0% |
| Intestinal Ischaemia |
3.0% |
| Multiple Drug Overdose Intentional |
3.0% |
|
| Concomitant |
| Prophylaxis |
21.4% |
| Drug Use For Unknown Indication |
19.0% |
| Product Used For Unknown Indication |
10.6% |
| Pain |
9.9% |
| Hypertension |
6.4% |
| Rheumatoid Arthritis |
5.1% |
| Prophylaxis Of Nausea And Vomiting |
3.3% |
| Diabetes Mellitus |
2.8% |
| B-cell Lymphoma |
2.3% |
| Depression |
2.3% |
| Thrombosis Prophylaxis |
2.2% |
| Nausea |
2.0% |
| Renal Cell Carcinoma |
2.0% |
| Non-small Cell Lung Cancer |
1.9% |
| Pain Prophylaxis |
1.9% |
| Hypothyroidism |
1.5% |
| Multiple Myeloma |
1.5% |
| Supplementation Therapy |
1.3% |
| Chronic Obstructive Pulmonary Disease |
1.3% |
| Breast Cancer |
1.3% |
|
| Vomiting |
12.6% |
| Pyrexia |
7.5% |
| Diarrhoea |
7.0% |
| Thrombocytopenia |
6.5% |
| Ataxia |
6.0% |
| Gastrointestinal Perforation |
6.0% |
| General Physical Health Deterioration |
6.0% |
| Renal Failure Acute |
5.5% |
| Drug Interaction |
4.5% |
| Pneumonia |
4.5% |
| Neutropenia |
4.0% |
| Respiratory Failure |
4.0% |
| Dyspnoea |
3.5% |
| Renal Failure |
3.5% |
| Weight Decreased |
3.5% |
| Asthenia |
3.0% |
| Delirium |
3.0% |
| Febrile Neutropenia |
3.0% |
| Infectious Peritonitis |
3.0% |
| Intestinal Fistula |
3.0% |
|
| Interacting |
|
|
